AbbVie Inc. (ABBV) Q4 2018 Earnings Results

AbbVie Misses on EPS — Stock Down 6.22%

AbbVie's earnings report indicates a slight miss on EPS, which contributed to a significant drop in stock price by 6.22%. Investors reacted negatively, likely due to the lack of revenue data and no guidance for future performance. The management's defensive tone suggests they are aware of current challenges but remain focused on long-term objectives.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.90	N/A	-3.61%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Defensive

Management expressed concerns over recent performance but remains committed to their strategic goals. They did not provide specific guidance for future quarters.

Management acknowledged the challenges faced in the quarter.

They emphasized a focus on long-term growth despite current setbacks.

AbbVie Misses on EPS — Stock Down 6.22%

Key numbers

Management commentary

AbbVie Inc.

More earnings this week

AbbVie Misses on EPS — Stock Down 6.22%

Key numbers

Management commentary